Whereas CCN2 has been strongly implicated in alcohol-, viral-, or toxin-mediated hepatic fibrosis in human or animal models, data are much less clear-cut in the context of NASH fibrosis. Here, CCN2 is linked to metabolic dysfunction-associated steatohepatitis.